Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BILI Bilibili	$19.22 -4.7%	$19.75	$10.79 ▼ $31.77	$8.35B	0.93	6.86 million shs	3.92 million shs
CPAY Corpay	$346.79 -2.4%	$363.75	$247.10 ▼ $400.81	$24.35B	1.25	473,564 shs	265,540 shs
GIB CGI	$98.09 -1.2%	$110.31	$96.92 ▼ $122.79	$22.24B	0.96	182,861 shs	164,945 shs
IQV IQVIA	$177.27 -1.2%	$193.15	$176.03 ▼ $253.84	$31.28B	1.5	1.30 million shs	1.58 million shs

The 10 Best Stocks to Own: Spring 2025

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BILI Bilibili	0.00%	-3.27%	-7.15%	+2.02%	+74.25%
CPAY Corpay	0.00%	-0.09%	-4.77%	+1.63%	+13.51%
GIB CGI	0.00%	-0.72%	-11.13%	-10.73%	-10.72%
IQV IQVIA	0.00%	-4.62%	-4.90%	-11.10%	-29.82%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BILI Bilibili	1.7504 of 5 stars	1.4	4.0	0.0	0.0	2.2	1.7	1.9
CPAY Corpay	4.1752 of 5 stars	3.4	5.0	0.0	0.0	3.0	2.5	2.5
GIB CGI	3.5894 of 5 stars	3.6	1.0	1.7	0.0	2.7	1.7	2.5
IQV IQVIA	4.7036 of 5 stars	4.4	3.0	0.0	4.6	3.0	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BILI Bilibili	2.85	Moderate Buy	$21.11	9.83% Upside
CPAY Corpay	2.87	Moderate Buy	$399.71	15.26% Upside
GIB CGI	3.17	Buy	$156.75	59.81% Upside
IQV IQVIA	2.86	Moderate Buy	$249.05	40.50% Upside

Current Analyst Ratings Breakdown

Latest BILI, IQV, CPAY, and GIB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/26/2025	GIB CGI	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$192.00 ➝ $192.00
3/4/2025	IQV IQVIA	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$225.00 ➝ $210.00
2/25/2025	BILI Bilibili	Nomura Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
2/21/2025	BILI Bilibili	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$24.00 ➝ $30.00
2/21/2025	BILI Bilibili	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$24.00 ➝ $25.00
2/18/2025	IQV IQVIA	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$240.00 ➝ $232.00
2/11/2025	IQV IQVIA	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$245.00 ➝ $250.00
2/10/2025	IQV IQVIA	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$270.00 ➝ $270.00
2/10/2025	IQV IQVIA	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$261.00 ➝ $263.00
2/7/2025	IQV IQVIA	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$260.00 ➝ $255.00
2/7/2025	IQV IQVIA	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$273.00 ➝ $261.00

(Data available from 3/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BILI Bilibili	$26.83B	0.30	N/A	N/A	$4.73 per share	4.06
CPAY Corpay	$3.97B	6.13	$23.20 per share	14.95	$45.13 per share	7.68
GIB CGI	$14.86B	1.50	$6.21 per share	15.80	$31.05 per share	3.16
IQV IQVIA	$15.41B	2.03	$15.18 per share	11.68	$34.45 per share	5.15

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BILI Bilibili	-$187.34M	-$0.45	N/A	42.71	N/A	-5.01%	-8.23%	-3.60%	5/22/2025 (Estimated)
CPAY Corpay	$1.00B	$13.98	24.81	14.97	1.32	25.25%	41.46%	7.55%	5/6/2025 (Estimated)
GIB CGI	$1.24B	$5.53	17.74	15.62	2.58	11.72%	19.32%	10.82%	4/30/2025 (Estimated)
IQV IQVIA	$1.37B	$7.50	23.64	14.53	1.99	8.91%	28.81%	7.02%	5/1/2025 (Estimated)

Latest BILI, IQV, CPAY, and GIB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
2/20/2025	Q4 2024	BILI Bilibili	$0.03	$0.05	+$0.02	$0.03	$1.05 billion	$1.08 billion
2/6/2025	Q4 2024	IQV IQVIA	$3.11	$2.90	-$0.21	$2.42	N/A	N/A
2/5/2025	Q4 2024	CPAY Corpay	$5.37	$4.96	-$0.41	$3.44	$1.05 billion	N/A
1/29/2025	Q1 2025	GIB CGI	$1.41	$1.41	N/A	$1.37	$2.70 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BILI Bilibili	N/A	N/A	N/A	N/A	N/A
CPAY Corpay	N/A	N/A	N/A	N/A	N/A
GIB CGI	$0.41	0.42%	N/A	7.41%	N/A
IQV IQVIA	N/A	N/A	N/A	N/A	N/A

Latest BILI, IQV, CPAY, and GIB Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
1/30/2025	GIB CGI	quarterly	$0.1039	0.3%	2/14/2025	2/14/2025	3/21/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BILI Bilibili	0.23	1.34	1.05
CPAY Corpay	1.66	1.00	1.05
GIB CGI	0.28	1.31	1.04
IQV IQVIA	2.12	0.84	0.84

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BILI Bilibili	16.08%
CPAY Corpay	98.84%
GIB CGI	66.68%
IQV IQVIA	89.62%

Insider Ownership

Company	Insider Ownership
BILI Bilibili	22.20%
CPAY Corpay	6.10%
GIB CGI	9.90%
IQV IQVIA	1.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BILI Bilibili	12,300	414.40 million	322.40 million	Optionable
CPAY Corpay	10,500	70.25 million	65.46 million	Optionable
GIB CGI	90,000	226.73 million	204.29 million	Optionable
IQV IQVIA	86,000	176.32 million	173.28 million	Optionable

BILI, IQV, CPAY, and GIB Headlines

Recent News About These Companies

Rep. Robert Bresnahan, Jr. Sells IQVIA Holdings Inc. (NYSE:IQV) Shares

March 30 at 8:02 AM | marketbeat.com

DnB Asset Management AS Grows Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

March 30 at 6:04 AM | marketbeat.com

New Age Alpha Advisors LLC Makes New $4.57 Million Investment in IQVIA Holdings Inc. (NYSE:IQV)

March 30 at 5:34 AM | marketbeat.com

IQVIA Holdings Inc. (NYSE:IQV) Stock Holdings Lifted by NEOS Investment Management LLC

March 30 at 5:17 AM | marketbeat.com

Elo Mutual Pension Insurance Co Acquires 2,777 Shares of IQVIA Holdings Inc. (NYSE:IQV)

March 30 at 5:09 AM | marketbeat.com

Korea Investment CORP Has $27.72 Million Stake in IQVIA Holdings Inc. (NYSE:IQV)

March 30 at 4:50 AM | marketbeat.com

Mitsubishi UFJ Trust & Banking Corp Trims Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

March 30 at 4:41 AM | marketbeat.com

Broadway Wealth Solutions Inc. Buys Shares of 1,396 IQVIA Holdings Inc. (NYSE:IQV)

March 29 at 6:40 AM | marketbeat.com

Meiji Yasuda Asset Management Co Ltd. Sells 9,354 Shares of IQVIA Holdings Inc. (NYSE:IQV)

March 29 at 4:54 AM | marketbeat.com

Corebridge Financial Inc. Decreases Position in IQVIA Holdings Inc. (NYSE:IQV)

March 29 at 4:37 AM | marketbeat.com

Sei Investments Co. Increases Stake in IQVIA Holdings Inc. (NYSE:IQV)

March 29 at 4:19 AM | marketbeat.com

India's pharma companies urge New Delhi to negotiate with US on tariffs from a position of strength

March 28 at 9:54 PM | msn.com

Truist Financial Remains a Buy on IQVIA Holdings (IQV)

March 28 at 9:54 PM | markets.businessinsider.com

Loomis Sayles & Co. L P Trims Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

March 28 at 6:49 AM | marketbeat.com

Sava Infond d.o.o. Takes Position in IQVIA Holdings Inc. (NYSE:IQV)

March 28 at 6:21 AM | marketbeat.com

IQVIA Holdings Inc. (NYSE:IQV) Stock Holdings Boosted by Mitsubishi UFJ Asset Management Co. Ltd.

March 28 at 6:05 AM | marketbeat.com

Prudential Financial Inc. Sells 9,505 Shares of IQVIA Holdings Inc. (NYSE:IQV)

March 28 at 4:49 AM | marketbeat.com

IQVIA (NYSE:IQV) Hits New 52-Week Low - Should You Sell?

March 27 at 3:05 PM | marketbeat.com

Hikma launches cisatracurium besylate, gets OK for Kloxxado in Canada

March 27 at 12:23 PM | drugstorenews.com

Teacher Retirement System of Texas Trims Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

March 27 at 4:05 AM | marketbeat.com

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

March 26, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Joby Aviation: From Prototype to Profitability
By Jeffrey Neal Johnson | March 11, 2025
View Joby Aviation: From Prototype to Profitability
4 EV Stocks Facing Uncertainty—Which Ones Will Survive?
By Thomas Hughes | March 7, 2025
View 4 EV Stocks Facing Uncertainty—Which Ones Will Survive?
3 Stocks With Ironclad Balance Sheets for Long-Term Stability
By Leo Miller | March 13, 2025
View 3 Stocks With Ironclad Balance Sheets for Long-Term Stability
If You Could Only Hold 3 Investments for Life, Consider These
By Chris Markoch | March 10, 2025
View If You Could Only Hold 3 Investments for Life, Consider These
Joby and Archer Lead the Charge in 2025’s Urban Air Revolution
By Jeffrey Neal Johnson | March 14, 2025
View Joby and Archer Lead the Charge in 2025’s Urban Air Revolution

BILI, IQV, CPAY, and GIB Company Descriptions

Bilibili NASDAQ:BILI

$19.22 -0.94 (-4.66%)

Closing price 03/28/2025 04:00 PM Eastern

Extended Trading

$19.20 -0.02 (-0.08%)

As of 03/28/2025 07:59 PM Eastern

Bilibili Inc. provides online entertainment services for the young generations in the People's Republic of China. It offers a range of digital content, including professional user generated videos, mobile games, and value-added services, such as live broadcasting, occupationally generated videos, audio drama on Maoer, and comics on Bilibili Comic. The company also provides advertising services; and IP derivatives and other services. In addition, it engages in the business and technology development activities; e-commerce business; and video, comics, and game distribution activities. Bilibili Inc. was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.

Corpay NYSE:CPAY

$346.79 -8.45 (-2.38%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$347.42 +0.63 (+0.18%)

As of 03/28/2025 05:31 PM Eastern

Corpay, Inc. operates as a payments company that helps businesses and consumers manage vehicle-related expenses, lodging expenses, and corporate payments in the United States, Brazil, the United Kingdom, and internationally. The company offers vehicle payment solutions, which include fuel, tolls, parking, fleet maintenance, and long-haul transportation services, as well as prepaid food and transportation vouchers and cards. It also provides corporate payment solutions consisting of accounts payable automation; virtual cards, cross-border solutions; and purchasing and travel and entertainment card products, as well as lodging payments solutions for employees who travel overnight for work purposes; traveling crews and stranded passengers from airlines and cruise lines; and insurance policyholders displaced from their homes due to damage or catastrophe. In addition, the company offers gifts and payroll cards. It serves business, merchant, consumer, and payment network customers. The company was formerly known as FLEETCOR Technologies, Inc. and changed its name to Corpay, Inc. in March 2024. Corpay, Inc. was founded in 1986 and is headquartered in Atlanta, Georgia.

CGI NYSE:GIB

$98.09 -1.17 (-1.18%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$98.12 +0.03 (+0.03%)

As of 03/28/2025 05:08 PM Eastern

CGI Inc., together with its subsidiaries, provides information technology (IT) and business process services. Its services include the business and strategic IT consulting, systems integration, and software solutions. The company also provides application development, modernization and maintenance, holistic enterprise digitization, automation, hybrid and cloud management, and business process services; intellectual property-based solutions; business consulting; managed IT services; and IT infrastructure services. It serves clients operating in government, banking and capital market, health, utility, communication and media, oil and gas, space, manufacturing, insurance, life sciences, retail and consumer service, and transportation and logistics sectors. The company operates in Canada, France, Spain, Portugal, the United States, Germany, Sweden, Norway, the United Kingdom, Australia, Finland, Poland, Baltics, the Netherlands, Denmark, Czech Republic, India, the Philippines, Asia Pacific, and internationally. Western and Southern Europe; Australia; Scandinavia; Finland, Poland, and Baltics; the United States; the United Kingdom; and the Asia Pacific. The company was formerly known as CGI Group Inc. and changed its name to CGI Inc. in January 2019. CGI Inc. was founded in 1976 and is headquartered in Montreal, Canada.

IQVIA NYSE:IQV

$177.26 -2.10 (-1.17%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$177.34 +0.08 (+0.04%)

As of 03/28/2025 07:35 PM Eastern

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time